AFP and eGFR are related to early and late recurrence of HCC following antiviral therapy

BACKGROUND: An unexpected recurrence of hepatocellular carcinoma (HCC) sometimes occurs in patients with hepatitis C virus (HCV) after treatment with direct-acting antivirals (DAAs). However, the characteristics of patients with HCC recurrence may differ depending on time after DAA treatment. We aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Takao, Tokumoto, Yoshio, Joko, Kouji, Michitaka, Kojiro, Horiike, Norio, Tanaka, Yoshinori, Tada, Fujimasa, Kisaka, Yoshiyasu, Nakanishi, Seiji, Yamauchi, Kazuhiko, Ochi, Hironori, Hiraoka, Atsushi, Yagi, Sen, Yukimoto, Atsushi, Hirooka, Masashi, Abe, Masanori, Hiasa, Yoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201700/
https://www.ncbi.nlm.nih.gov/pubmed/34126947
http://dx.doi.org/10.1186/s12885-021-08401-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201700/
https://www.ncbi.nlm.nih.gov/pubmed/34126947
http://dx.doi.org/10.1186/s12885-021-08401-7

Ejemplares similares